Mortality & Morbidity Liaison Committee

 

Google Search

Home | Committee| Publications

WHAT'S NEW

MMLC - ISCS Body Mass Index Study

© Copyright by American Academy of Insurance Medicine 2003

 

ORDER MMLC PUBLICATIONS

A Descriptive Index of Mortality Studies From Selected Sources 1951-1995
A Descriptive Index of Mortality Studies from Selected Sources 1951-1995

Multiple Medical Impairment Study

 

 

 

 

 

 

 

 

 

 

 


MESSAGE FROM MMLC CHAIRPERSON
Bradley T. Roudebush, FSA, MAAA

The accurate assessment of risk in insurance applicants is imperative to the industry's credibility.  This committee of actuaries, medical directors, and underwriters brings decades of experience to the task and approaches the work with integrity and enthusiasm.


The MMLC
The Mortality and Morbidity Liaison Committee (MMLC), consists of members representing the Society of Actuaries (SOA), the American Academy of Insurance Medicine (AAIM), and the Association of Home Office Underwriters (AHOU). Members from each of the respective professional organizations are involved in life insurance risk assessment. The MMLC's purpose is to produce experience studies that support the risk management information needs of those involved in pricing and underwriting individual life and disability products in the United States and Canada.

The Mission
The mission of the MMLC is to promote and facilitate the preparation and dissemination of mortality and morbidity information on medical impairments; other medical form of insurance and non-insurance sources. This can be accomplished through the interdisciplinary cooperation of medical directors, actuaries, and underwriters, who assist to preserve the use and integrity of the risk classification process. The risk classification or methodology is a process that the industry uses to determined mortality and morbidity in experience studies.

  • To promote the compilation and processing of intercompany mortality and morbidity studies.

  • To represent the interests of the three parent organizations and the industry.

  • To judiciously utilize the resources of the mortality surcharge on the MIB assessment for the production and publication of mortality and morbidity studies.

  • To focus on studying impairments that are significant to the risk assessment process.

    Updated 10/4/2007

 

This website is optimized for use with Microsoft Internet Explorer 5.0 and above

Site Map | Privacy Policy | ©2003-07 | MIB Solutions, Inc. | 50 Braintree Hill Park | Braintree, MA 02184